AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Founded Date:
N/A
Employee Number:
N/A
Technology:
COVID
Investor Type:
N/A
Headquarters:
Denmark
Number Of Exists:
N/A
Funding Status:
N/A
Investment Stage:
N/A
Industry:
Vaccine/Drug